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DObjective: A high body mass index has been suggested to be protective in patients with coronary artery disease
and in those undergoing coronary artery bypass grafting (CABG). However, these conflicting results might be
related to the different risk profiles among the various bodymass index categories.We sought to clarify the effect
of varying degrees of excessive body weight on hard clinical outcomes in patients undergoing CABG.
Methods: A retrospective analysis of prospectively collected data was conducted to investigate the effect of
a high body mass index on early and late mortality after first-time isolated CABG. Propensity score matching
was used to adjust for confounding factors.
Results: The study sample consisted of 3269 normal weight, 6662 overweight, 3821 obese, and 211 morbidly
obese patients. After matching, early mortality was not affected by overweight (mean difference, 0.7%; 95%
confidence interval [CI], 0.2% to 1.5%), obesity (mean difference, 0.5%; 95% CI, 0.7% to 1.7%), and
morbid obesity (mean difference, 1.6%; 95% CI, 1.0% to 1.0%), regardless of the patients’ risk profile
according to the European system for cardiac operative risk evaluation. Overweight status was not protective
for late death (hazard ratio, 1.05; 95% CI, 0.9-1.08; P¼ .4). Compared with normal weight patients, both obese
and morbidly obese patients had a higher risk of late death (hazard ratio, 1.22; 95% CI, 1.07-2.66; P¼ .006 for
obese patients; hazard ratio, 1.36; 95% CI, 0.74-2.49; P ¼ .3 for morbidly obese patients).
Conclusions: Obesity did not increase operative mortality, but it was associated with reduced late survival in
patients undergoing primary isolated CABG. Our results raise concerns in supporting any protective effect of
obesity in cardiovascular disease, specifically in patients undergoing surgical myocardial revascularization.
(J Thorac Cardiovasc Surg 2014;147:1517-23)According to the World Health Organization, the preva-
lence of obesity nearly doubled from 1980 to 2008, with
more than 1.4 billion adults being overweight and more
than half a billion obese. At least 2.8 million people die
annually as a result of being overweight or obese. Obesity
is a well known cardiometabolic risk factor, and the
prevalence of almost every cardiovascular disease, inclu-
ding hypertension, heart failure, peripheral arterial disease,
atrial fibrillation, and coronary artery disease, is markedly
increased in the presence of obesity.1 However, despite
these adverse effects of obesity, numerous studies have
suggested the existence of an ‘‘obesity paradox,’’ according
to which normal weight patients with established coronary
artery disease have a worse clinical prognosis than their
more overweight or obese counterparts.2
The number of obese patients referred for coronary ar-
tery bypass grafting (CABG) has been increasing.3 Obese
patients have traditionally been considered at higher riske Cardiothoracic Department, Papworth Hospital, National Health Service
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The Journal of Thoracic and Carof perioperative morbidity and mortality, and, occasionally,
they have not even been considered suitable for surgery
solely because of their obese status. However, con-
flicting results have recently been reported,4-8 with some
investigations showing that a high body mass index
(BMI) might even have a beneficial effect on early and
late mortality, supporting the existence of an ‘‘obesity
paradox’’ in patients undergoing CABG.4-7 The
biological basis for this seemingly contradictory clinical
observation remains unclear. One possible explanation
can be found in the different characteristics of patients
in the obese and normal weight groups. For example,
overweight and obese patients were reported to be
significantly younger than the normal weight patients at
the time of CABG.4-7 Therefore, the different risk profile,
rather than obesity per se, might have accounted for the
apparently better prognosis of this patient population. To
date, only a few studies have reported on the effect of
a high BMI on survival after CABG, with several
limitations, including a small sample size and significant
differences in baseline characteristics in patients across
the different BMI categories. Because obesity is
a potentially treatable condition,9 additional studies are
warranted to confirm or refute this ‘‘obesity paradox’’
and to improve the treatment of such challenging patients.
Using a large database with 17 years of follow-up, we
investigated the effect of a high BMI on the early and late
mortality of patients undergoing first-time isolated CABG.diovascular Surgery c Volume 147, Number 5 1517
Abbreviations and Acronyms
BMI ¼ body mass index
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
EuroSCORE ¼ European system for cardiac
operative risk evaluation
HR ¼ hazard ratio
OR ¼ odds ratio
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DMETHODS
Study Population
The present study was performed with permission from the local med-
ical ethics committee. We retrospectively analyzed prospectively collected
data from the surgical database of Papworth Hospital (Cambridge, UK).
This database is maintained by a team of full-time clinical information
analysts, who are responsible for continuous prospective data collection
as a part of a continuous audit process that is linked to a national database.
Data collection is validated regularly. Information about death from any
cause is obtained from the General Register Office approximately 1
week after the event. Patients undergoing first-time isolated CABG from
March 1996 to May 2012 were included in the present analysis. Patients
with missing data on important baseline clinical covariates were excluded
from the study sample.
The patients were divided into 5 groups according to their BMI: under-
weight (BMI<18.5 kg/m2), normal weight (BMI, 18.5-24.9 kg/m2), over-
weight (BMI, 25-29.9 kg/m2), obese (BMI, 30-34.9 kg/m2), and morbidly
obese (BMI  35 kg/m2). Because of the small sample size (n ¼ 67),
underweight patients were not included in the present analysis.
The primary endpoints were all-cause early (within 30 days or hospital
discharge, whichever was earlier) and late (>30 days or after hospital dis-
charge) death. We focused on all-cause death, which represents the most
robust and unbiased index event, because no adjudication was required,
thus avoiding inaccurate or biased documentation and clinical assessments.
Statistical Analysis
Baseline risk factors were selected among the variables included in the
European system for cardiac operative risk evaluation (EuroSCORE).10
The year of the operation was included in the analysis to correct for variable
standards of perioperative care over time. Operative risk was derived by cal-
culating the logistic EuroSCORE. The additive EuroSCORE was used to
classify the patient risk profile into 3 groups: low risk (0-2), with an expected
mortality of<2%; medium risk (3-5), with an expected mortality of<5%;
and high risk (6), with an expected mortality of>6%.10
The results are presented as the mean  standard deviation for contin-
uous variables and as proportions for categorical variables, according to the
stated BMI categories.
Before matching, an analysis of the unmatched patient population was
conducted to assess the effect of a high BMI on early and late mortality us-
ing logistic and Cox regression analysis, respectively, after adjusting for all
covariates significantly associated with the chosen endpoints on univariate
analysis (P<.5). The BMI was forced into the models as a categorized and
continuous variable, using normal weight as the control.
Propensity score matching was used to minimize the bias related to the
baseline differences among the BMI groups.11 To estimate the propensity
score, 3 logistic regression models were used, in which the BMI categories
were regressed on the baseline characteristics listed in Table 1. Pairs of nor-
mal weight versus overweight, obese, and morbidly obese patients were de-
rived using 1:1 matching. To optimize the matching process, we used
‘‘optimal’’ matching implemented by the MatchIt package (R project, R
Foundation for Statistical Analysis, Vienna, Austria),11 which finds the1518 The Journal of Thoracic and Cardiovascular Surmatched samples with the smallest average absolute distance across all
the matched pairs. The commonly used nearest-neighbor matching method
is greedy matching, in which the closest control match for each treated unit
is chosen 1 at a time, without trying to minimize a global distance measure.
The standardized mean difference was used to quantify the differences in
the mean or prevalence between overweight and obese versus normal
weight patients in the overall sample size and in the matched samples;
a value>0.10 represented a meaningful imbalance in a given covariate.12
The difference in the probability of 30-day mortality among the BMI
groups was assessed by directly estimating the difference in proportions
among the BMI categories in the matched samples.11 To investigate the ef-
fect of patient risk profile on early mortality in the BMI categories, we con-
ducted a separate analysis according to 3 EuroSCORE risk groups (low,
medium, and high risk, as previously specified).
The effect of the BMI categories on the interval to late death (>30 days)
was assessed using Kaplan-Meier survival curves in the matched samples
and the stratified log-rank method.12
All statistical analyses were performed using R, version 2.15.2 (R Foun-
dation for Statistical Analysis).
RESULTS
Baseline
The study sample consisted of 3269 normal weight, 6662
overweight, 3821 obese, and 211 morbidly obese patients.
The baseline characteristics of the patients according to
BMI status are listed in Table 1. Several variables had stan-
dardized differences that exceeded 0.10, indicating signifi-
cant differences in the baseline characteristics among the
overweight, obese, and morbidly obese patients versus the
normal weight patients. Normal weight patients tended to
be older, more likely to have extracardiac arteriopathy,
and to have an increased serum creatinine. They were
more likely to undergo nonelective CABG. Subjects with
a normal BMI presented with an increased overall risk pro-
file, as assessed by the logistic EuroSCORE (5.9% 
8.5%) compared with overweight (4.7%  6.8%; analysis
of variance, P< .05 vs normal weight), obese (4.3% 
6.9%, P < .05 vs normal weight), and morbidly obese
(3.6%  5.3%; P<.05 vs normal weight) patients.
Unmatched Sample Analysis
In the unmatched sample, crude mortality within 30 days
for normal weight, overweight, obese, and morbidly obese
patients was 3.81%, 1.99%, 2.23%, and 1.43%, respec-
tively. After adjusting for other risk factors, overweight sta-
tus showed a protective effect on early mortality compared
with normal weight (odds ratio [OR], 0.62; 95% CI, 0.48-
0.81; P ¼ .0005). However, this protective effect was no
longer significant in the obese (OR, 0.79; 95% CI, 0.58-
1.08; P ¼ .14) and morbidly obese (OR, 0.74; 95% CI,
0.22-2.41; P¼ .6) patients. When the analysis was conduct-
ed according to the patient risk profile, being overweight
was protective for high-risk (P ¼ .004) and medium-risk
(P ¼ .02) but not for low-risk (P ¼ .7) profile patients. As
a continuous variable, BMI showed a U-shaped effect on
the adjusted risk of early mortality with a significant risk
reduction for BMI values of 26 to 32 kg/m2 (Figure 1, top).gery c May 2014
TABLE 1. Baseline characteristics among all unmatched cases
Characteristic
Normal weight
(n ¼ 3269)
Overweight
(n ¼ 6662)
Obese
(n ¼ 3821)
Morbidly obese
(n ¼ 211)
SMD
Normal vs
overweight
Normal vs
obese
Normal vs
morbidly obese
Age (y) 68  9 66  9 64  9 60  9 0.17 0.39 0.83
Female gender (%) 0.22 0.15 0.20 0.37 0.15 0.04 0.34
Creatinine (mmol/L) 108  61 108  21 104  44 100  33 0.001 0.01 0.23
LV dysfunction (%) 0.46 0.46 0.47 0.53 0.004 0.02 0.12
IDDM (%) 0.12 0.14 0.19 0.22 0.01 0.07 0.1
COPD (%) 0.10 0.09 0.11 0.13 0.04 0.01 0.03
Extracardiac arteriopathy (%) 0.10 0.10 0.09 0.07 0.01 0.03 0.1
CVA (%) 0.01 0.01 0.01 0.01 0.007 0.01 0.02
Nonelective surgery (%) 0.27 0.20 0.19 0.22 0.16 0.18 0.09
Redo surgery (%) 0.03 0.03 0.03 0.04 0.0049 0.005 0.07
Year of operation (median) 2003 2003 2004 2005 0.04 0.21 0.53
Data are presented as mean  standard deviation, unless otherwise noted. SMD, Standardized mean difference; LV, left ventricle; IDDM, insulin-dependent diabetes mellitus;
CVA, cerebrovascular accident; COPD, chronic obstructive pulmonary disease.
FIGURE 1. Relationship between body mass index (BMI) as a continuous
variable and risk for early (top) and late (bottom) mortality in the
unmatched sample. OR, Odds ratio; HR, hazard ratio; LL, lower limit of
95% confidence interval; UL, upper limit of 95% confidence interval.
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DAmong the operative survivors, the mean follow-up time
was 7.6  4.5 years. Late survival at 5 years was 90.1% 
0.5%, 92.6% 0.3%, 92.2% 0.4%, and 91.6% 2.2%
for normal weight, overweight, obese, and morbidly obese
patients, respectively. After adjusting for other risk factors,
overweight status showed a protective effect on late mortal-
ity compared with normal weight (hazard ratio [HR], 0.88;
95% CI, 0.80-0.97; P¼ .018). Obesity (HR, 1.04; 95% CI,
0.93-1.17; P¼ .43) and morbid obesity (OR, 1.29; 95% CI,
0.85-1.96; P ¼ .2) did not influence late survival compared
with normal weight.
When BMI was investigated as a continuous variable, it
was shown to be significantly protective for late mortality
only for a BMI of 27 to 29 kg/m2 (Figure 1, bottom).
Propensity Score Matching Analysis
After propensity matching, 3072 matched pairs of over-
weight versus normal weight patients were identified. The
baseline characteristics of the 2 matched samples are listed
in Table 2. The standardized difference was<0.1 for all co-
variates investigated, indicating that the 2 groups were very
similar. No difference was found in 30-day mortality among
overweight and normal weight patients (mean difference,
0.7%; 95% CI, 0.2% to 1.5%). This result was con-
firmed in the low-risk (P ¼ .4), medium-risk (P ¼ .2),
and high-risk (P ¼ .1) patients. After a mean follow-up of
7.5  4.6 years (range 0-17), overweight patients had late
survival comparable to that in the normal weight group
(HR, 1.05; 95% CI, 0.9-1.08; P ¼ .4; Figure 2).
A total of 1609 matched pairs of obese versus normal
weight subjects were formed, and the 2 groups were compa-
rable in respect to all risk factors thought to influence the
chosen outcome measures (Table 3). No difference was
found in 30-day mortality between the obese and normal
weight patients (mean difference, 0.5%; 95% CI, 0.7%
to 1.7%). This result was confirmed in the low-riskThe Journal of Thoracic and Car(P ¼ .1), medium-risk (P ¼ .1), and high-risk (P ¼ .9) pa-
tients. However, after a mean follow-up of 7.1  4.5 years
(range, 0-17), obesity was associated with an increased risk
of late death compared with normal weight (HR, 1.22; 95%diovascular Surgery c Volume 147, Number 5 1519
TABLE 2. Baseline characteristics among normal weight and overweight subjects after matching
Variable Normal weight (n ¼ 3072) Overweight (n ¼ 3072)
SMD
Normal vs overweight Balance improvement (%)
Age (y) 68.1 68.6 0.04 74
Female gender (%) 0.21 0.21 0.007 95
Creatinine (mmol/L) 108 108 0.001 8
LV dysfunction (%) 0.46 0.46 0.003 8
IDDM (%) 0.12 0.12 0.001 8
COPD (%) 0.10 0.10 0.01 67
Extracardiac arteriopathy (%) 0.10 0.10 0.002 87
CVA (%) 0.01 0.01 0.003 60
Nonelective surgery (%) 0.26 0.26 0.002 98
Redo surgery (%) 0.033 0.038 0.02 47
Year of operation (median) 2003 2003 0.0003 99
Data are presented as mean values, unless otherwise noted. SMD, Standardized mean difference; LV, left ventricle; IDDM, insulin-dependent diabetes mellitus; CVA, cerebro-
vascular accident; COPD, chronic obstructive pulmonary disease.
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DCI, 1.07-2.66; P ¼ .006; Figure 3), with an absolute in-
creased risk of 22%.
Finally, 203 matched pairs of morbidly obese versus nor-
mal weight patients were identified, and, again, all covari-
ates were well balanced (Table 4). No difference was
found in 30-day mortality between morbidly obese and
normal weight patients (mean difference, 0.6%; 95%
CI, 1.0% to 1.0%). This result was confirmed in the
low-risk (P ¼ .4), medium-risk (P ¼ .9), and high-risk
(P ¼ .8) patients. After a mean follow-up period of 6.0 
4.2 years (range, 0-15), morbidly obese patients tended to
show an increased risk of late mortality compared with nor-
mal weight patients (HR, 1.36; 95% CI, 0.74-2.49; P ¼ .3;
Figure 4), with an absolute increased risk of 36%.DISCUSSION
In contrast to previous reports suggesting the existence of
an ‘‘obesity paradox’’ in patients undergoing CABG,4-7 theFIGURE 2. Kaplan-Meier curves with log-rank test result for late survival
among matched normal weight and overweight subjects. HR, Hazard ratio.
1520 The Journal of Thoracic and Cardiovascular Surpresent propensity score-matched analysis showed that
obesity did not confer any protective effect on early and
late mortality when the baseline risk factors were well
balanced. As previously reported, our data have shown
that obesity and morbid obesity, per se, does not increase
operative mortality even in medium- and high-risk patients,
as identified by the EuroSCORE. However, obesity
and morbid obesity were associated with a significantly
increased risk of late mortality.
As shown in previous studies, the present analysis
identified an inverse relationship between age and BMI
categories, with obese patients younger than normal
BMI patients.4-7 This finding was likely because of the
influence of obesity-related metabolic alterations on
accelerating the pathogenesis of coronary artery disease,
resulting in a younger age at presentation.
Obesity is considered a major risk factor for cardiovascu-
lar disease, hypertension, and diabetes by National and
International Committees.1 Thus, weight loss and preven-
tion of obesity through dietary modifications and increased
levels of exercise have been advocated.13,14 However,
several studies of patients with established coronary artery
disease, including patients undergoing CABG, have
shown more favorable short-term and long-term survival
for patients with a higher BMI, implying a possible
protective effect of obesity, defining the so-called
obesity paradox.4,7 The main limitations of the previous
reports were the small sample sizes and the significant
differences in the baseline characteristics of patients
belonging to different BMI categories.
Given the ever-increasing incidence of obesity and asso-
ciated cardiometabolic disorders in Western countries, cau-
tion should be exercised in supporting a protective effect of
obesity, unless conclusively proven true. By considering the
demographic data of previously published studies, it could
be argued that patients with a high BMI had better survival
because of their better risk profile compared with that ofgery c May 2014
TABLE 3. Baseline characteristics among normal weight and obese subjects after matching
Variable Normal weight (n ¼ 1609) Obese (n ¼ 1609)
SMD
Normal weight vs obese Balance improvement (%)
Age (y) 67.3 67.7 0.04 87
Female gender (%) 0.23 0.24 0.03 29
Creatinine (mmol/L) 105 104 0.01 25
LV dysfunction (%) 0.47 0.46 0.03 32
IDDM (%) 0.12 0.13 0.02 33
COPD (%) 0.11 0.10 0.01 4.18
Extracardiac arteriopathy (%) 0.12 0.10 0.07 90.21
CVA (%) 0.01 0.01 0.05 181
Nonelective surgery (%) 0.24 0.23 0.02 85
Redo surgery (%) 0.036 0.037 0.005 78
Year of operation 2003.90 2003.63 0.05 73
SMD, Standardized mean difference; LV, left ventricle; IDDM, insulin-dependent diabetes mellitus; CVA, cerebrovascular accident; COPD, chronic obstructive pulmonary
disease.
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Dnormal weight patients,4-7 in particular, their younger age.
Therefore, the so-called obesity paradox might simply be
related to the fact that patients referred to surgery at a youn-
ger age have better survival in the short and medium term.
In observational studies comparing treatment options or
the effect of various factors on clinical endpoints, the
groups compared have often been different because of
a lack of randomization. If the compared groups also
differed between each other in respect to other variables
that might have an effect on the chosen outcome measures,
a direct comparison of the study groups would likely
produce biased conclusions that might merely reflect the
lack of initial comparability. To minimize the risk of such
flawed conclusions, propensity score matching has been
shown to produce estimates that are less biased, more
robust, and more precise than the logistic regression
estimates, especially for low rate outcomes such as death.15
In a relatively small sample size of heterogeneous pa-
tients, Stamou et al4 reported lower in-hospital mortalityFIGURE 3. Kaplan-Meier curves with log-rank test result for late survival
among matched normal weight and obese subjects. HR, Hazard ratio.
The Journal of Thoracic and Carand better long-term survival among overweight patients.
Obese and morbidly obese patients had similar outcomes
compared with normal weight patients. However, normal
weight patients were significantly younger and had a higher
incidence of congestive heart failure and left ventricular
dysfunction. The investigators used propensity score
matching for balancing covariates; however, the results of
the balancing process were not reported. The better long-
term survival among overweight patients was mainly re-
lated to the early phase, suggesting that residual differences
in the patient risk profile could have influenced the results.
Finally, even if no caliper of width was used for matching, it
remains unclear why the matched sample size of normal
weight patients was significantly smaller and thus affecting
the power of the analysis. Sung et al7 concluded that over-
weight status is associated with improved survival after
CABG. However, these investigators included a very small
number of patients with significant differences in risk
profiles between normal and overweight patients. The
normal weight patients were significantly older and were
more likely to have acute coronary syndrome, depressed
left ventricular function, and decreased renal function.
Furthermore, no propensity score matching was used to
adjust for confounding factors. These limitations make their
conclusion less reliable.
However, van Straten et al8 investigated the effect of the
BMI on a large number of patients and concluded that
overweight status did not confer a survival advantage. In
contrast, they found that morbid obesity actually reduced
late survival.8 Of note, the mean age among the normal
weight and overweight patients was comparable. However,
the results of the Bypass Angioplasty Revascularization
Investigation trial3 showed that although in-hospital
complications were not adversely affected by obesity in
the CABG population, the 5-year mortality progressively
increased by up to fivefold with greater obesity.
The present propensity score analysis compared
the effect of BMI in a large number of patients duringdiovascular Surgery c Volume 147, Number 5 1521
TABLE 4. Baseline characteristics among normal weight and morbidly obese subjects after matching
Variable Normal weight (n ¼ 203) Morbidly obese (n ¼ 203)
SMD
Normal weight vs
morbidly obese Balance improvement (%)
Age (y) 61.0 61.0 0.001 99
Female gender (%) 0.36 0.37 0.02 93
Creatinine (mmol/L) 101 100 0.02 88
LV dysfunction (%) 0.49 0.50 0.03 71
IDDM (%) 0.20 0.20 0.01 33
COPD (%) 0.11 0.09 0.06 11
Extracardiac arteriopathy (%) 0.09 0.07 0.05 49
CVA (%) 0.004 0.009 0.05 107
Nonelective surgery (%) 0.24 0.22 0.03 89
Redo surgery (%) 0.029 0.049 0.09 39
Year of operation (median) 2003 2003 0.05 73
Data are presented as mean values, unless otherwise noted. SMD, Standardized mean difference; LV, left ventricle; IDDM, insulin-dependent diabetes mellitus; CVA, cerebro-
vascular accident; COPD, chronic obstructive pulmonary disease.
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Dlong-term follow-up. In the present study, a high BMI was
associated with a better risk profile according to the
EuroSCORE, and this could be partially explained by the
younger age of the obese patients. Before matching, over-
weight status appeared to be protective for early and late
mortality. This result seemed to be primarily justified by
a residual difference in the risk profile among the 2 groups,
despite multivariate adjustment. In addition, when the BMI
was considered as a continuous variable, the observed
benefit on late survival was present for a short range of
BMI values (27 and 28 kg/m2), suggesting that confounding
factors might have influenced this result.
After propensity matching, all baseline characteristics
were well balanced among the BMI groups. In the
matched sample, overweight status was no longer protec-
tive for early and late mortality. In accordance withFIGURE 4. Kaplan-Meier curves with log-rank test result for late survival
among matched normal weight and morbidly obese subjects. HR, Hazard
ratio.
1522 The Journal of Thoracic and Cardiovascular Surprevious reports,5,8 obesity and morbid obesity status
per se did not increase perioperative mortality,
regardless of the patient risk profile. However, both
obesity and morbid obesity status were associated with
an absolute increased risk of late death of 22% and
38%, respectively.
Study Limitations
The present study has some limitations. Because of the
small number of morbidly obese patients, the analysis of
late mortality did not reach statistical significance. The
rate of diabetic patients taking insulin was not significantly
higher among patients with a high BMI. To explain this
observation, it would be reasonable to speculate that
obese patients with diabetes are treated more readily and
aggressively with oral antidiabetic medications in an
attempt to reduce insulin resistance.
We did not measure the changes in the BMI during the
follow-up period; hence, no causality of the interrelationship
between these parameters could be determined. In addition,
obesity was defined only by the BMI in the present study,
rather than by an actual measure of adiposity, such as the
waist circumference. A recent study of the association of
different measures of obesity and mortality reported that
a high BMI is not directly associated with mortality and
suggested that the waist circumference and waist-to-height
ratiowould bemore reliable parameters to assess the mortal-
ity risk in patients with coronary artery disease.14 In
addition, the combination of body fat and BMI was shown
to be a better predictor of late survival than the BMI alone.16
However, the BMI is a widely available, simple, and
practical obesity measurement, and numerous studies have
used BMI as a surrogate measure of adiposity. However,
an accurate quantitative measurement of lean and fat tissue
and central adiposity should be performed in future
studies. Finally, we were unable to assess the effect ofgery c May 2014
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Dcardiorespiratory fitness, which has been shown to influence
the effect of obesity on late survival.17
CONCLUSIONS
Our results support the findings of previous studies show-
ing that obesity is a major risk factor in cardiovascular
disease,1,2 and did not show any protective effect of
obesity toward early and late mortality in patients
with cardiovascular disease, thus confuting the so-called
obesity paradox. From the present findings, obese and
morbidly obese patients should not be denied the benefits of
CABG, because obesity per se does not increase early morta-
lity, even in high-risk patients. However, robust postoperative
weight loss programs should be strongly recommended for
patients undergoing surgical myocardial revascularization,
because obesity is associated with an absolute increased
risk of 22% to 34% for late mortality after CABG.
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